Suppr超能文献

儿童急性胃肠炎的止吐药物治疗:一项荟萃分析。

Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis.

机构信息

Department of Pediatrics, University of Antioquia, Medellín, Colombia.

Hospital Pablo Tobón Uribe, Medellín, Colombia.

出版信息

Pediatrics. 2020 Apr;145(4). doi: 10.1542/peds.2019-3260. Epub 2020 Mar 4.

Abstract

CONTEXT

Several antiemetics have been used in children with acute gastroenteritis. However, there is still controversy over their use.

OBJECTIVE

To determine the effectiveness and safety of antiemetics for controlling vomiting in children with acute gastroenteritis.

DATA SOURCES

Medline, Embase, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, Latin America and the Caribbean Literature on Health Sciences, and gray literature, until December 2018.

STUDY SELECTION

We selected randomized clinical trials comparing metoclopramide, ondansetron, domperidone, dexamethasone, dimenhydrinate, and granisetron.

DATA EXTRACTION

Two reviewers independently screened abstracts and full texts, extracted the data, and assessed the risk of bias. We performed pairwise and network meta-analysis using the random-effects model.

RESULTS

Twenty-four studies were included (3482 children). Ondansetron revealed the largest effect in comparison to placebo for cessation of vomiting (odds ratio = 0.28 [95% credible interval = 0.16 to 0.46]; quality of evidence: high) and for hospitalization (odds ratio = 2.93 [95% credible interval = 1.69 to 6.18]; quality of evidence: moderate). Ondansetron was the only intervention that reduced the need for intravenous rehydration and the number of vomiting episodes. When considering side effects, dimenhydrinate was the only intervention that was worse than placebo.

LIMITATIONS

Most treatment comparisons had low- or very low-quality evidence, because of risk of biases and imprecise estimates.

CONCLUSIONS

Ondansetron is the only intervention that revealed an effect on the cessation of vomiting, on preventing hospitalizations, and in reducing the need for intravenous rehydration. Ondansetron was also considered a safe intervention.

摘要

背景

已有多种止吐药物被用于治疗儿童急性肠胃炎,但它们的使用仍存在争议。

目的

评估止吐药物治疗儿童急性肠胃炎呕吐的疗效和安全性。

资料来源

检索 Medline、Embase、Cochrane 对照试验中心注册库、护理学及相关健康领域文献累积索引、拉丁美洲和加勒比健康科学文献、灰色文献,检索时间截至 2018 年 12 月。

研究选择

纳入比较甲氧氯普胺、昂丹司琼、多潘立酮、地塞米松、茶苯海明和格拉司琼的随机对照临床试验。

资料提取

两位评价员独立筛选摘要和全文、提取资料并评估偏倚风险,采用随机效应模型进行二分类资料和网状 Meta 分析。

结果

共纳入 24 项研究(3482 例患儿)。与安慰剂相比,昂丹司琼在停止呕吐(比值比=0.28,95%可信区间:0.160.46;证据质量:高)和住院(比值比=2.93,95%可信区间:1.696.18;证据质量:中)方面的效果最大。昂丹司琼是唯一能减少静脉补液和呕吐发作次数的干预措施。考虑到不良反应,只有茶苯海明比安慰剂差。

局限性

大多数治疗比较的证据质量为低或极低,因为存在偏倚风险和估计不精确。

结论

昂丹司琼是唯一能有效缓解呕吐、减少住院和降低静脉补液需求的干预措施,且被认为是一种安全的干预措施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验